Repligen traded at $168.45 this Wednesday July 6th, increasing $0.77 or 0.46 percent since the previous trading session. Looking back, over the last four weeks, Repligen gained 0.62 percent. Over the last 12 months, its price fell by 18.41 percent. Looking ahead, we forecast Repligen to be priced at 162.01 by the end of this quarter and at 149.19 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Agilent 121.18 0.62 0.51% -18.94%
Align Technology 249.54 -4.57 -1.80% -59.24%
BioMarin Pharmaceutical 86.41 0.05 0.06% 4.06%
Bristol-Myers Squibb 76.22 0.26 0.34% 13.52%
Bruker 64.55 -0.44 -0.68% -18.51%
Charles River Laboratories 226.01 3.29 1.48% -41.02%
Catalent 109.20 3.21 3.03% -4.70%
Danaher 260.04 4.53 1.77% -6.65%
Exact Sciences 43.29 -1.11 -2.50% -63.23%
Standard Biotools Inc 1.69 -0.05 -2.87% -71.36%
General Electric 61.57 -0.46 -0.74% -40.71%
Genesis Healthcare 0.10 0 0% -63.98%
Henry Schein 76.30 0.15 0.20% -0.48%
Illumina 195.39 2.37 1.23% -58.73%
IQVIA Holdings Inc 216.00 0.69 0.32% -14.94%
Mettler Toledo International 1,171.60 -3.87 -0.33% -18.41%
Myriad Genetics 19.01 0.17 0.90% -40.69%
NanoString Technologies 14.37 0.27 1.91% -76.89%
OraSure Technologies 2.77 -0.01 -0.36% -72.76%
Pacific Biosciences Of California 5.15 -0.05 -0.96% -83.96%
Patterson Companies 29.23 -0.86 -2.86% -2.92%
Pfizer 52.75 1.11 2.15% 34.05%
PerkinElmer 145.99 1.43 0.99% -5.84%
Peregrine Pharmaceuticals 16.71 0.35 2.14% -36.92%
Repligen 168.45 0.77 0.46% -18.41%
Bio Techne 362.78 0.48 0.13% -21.77%
Thermo Fisher Scientific 556.04 10.97 2.01% 6.37%
Waters 342.27 2.61 0.77% -6.33%
West Pharmaceutical Services 315.55 9.49 3.10% -15.33%
Dentsply International 35.62 -0.48 -1.33% -44.02%

Indexes Price Day Year
USND 11362 39.61 0.35% -22.52%
US2000 1728 -13.78 -0.79% -23.32%
US400 2279 -13.85 -0.60% -15.05%

Repligen
Repligen Corporation is a life sciences company that develops and commercializes bioprocessing technologies and systems that rises flexibility in the process of manufacturing biological drugs. The Company's bioprocessing business consist of four franchises, Filtration; Chromatography; Process Analytics; and Proteins. The Filtration products are used in process development and process scale (clinical and commercial) production. The Chromatography franchise includes products used in downstream purification, development, and manufacturing of biological drugs. The Process Analytics products allow end-users to make in-line absorbance measurements allowing for the determination of protein concentration in filtration, chromatography formulation and fill-finish applications. The Proteins franchise is represented by its Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification of virtually all mAb-based drugs on the market.